Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Autophagy is a fundamental cellular process in which cells degrade and recycle their own components through a lysosome-dependent pathway. This mechanism is essential for maintaining cellular health by removing unnecessary or dysfunctional organelles, misfolded proteins, and intracellular pathogens. There are three main types of autophagy—macroautophagy, microautophagy, and chaperone-mediated autophagy—each differing in how cellular material is delivered to the lysosome for degradation. Autophagy plays critical roles in energy homeostasis during nutrient deprivation, quality control by preventing accumulation of damaged components, immune defense against infections, regulation of cell death pathways, and protection against aging-related damage. Dysregulation or deficiency in autophagic processes has been implicated in various diseases including cancer and neurodegenerative disorders[1][2][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Autophagy process.